Pricing Log in Create free account

Genelux Corporation (GNLX) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Genelux Corporation and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Genelux Corporation and Tonix Pharmaceuticals Holding Corp. are of similar size ($112.2M and $110.1M). Genelux Corporation has the higher net margin (0.00% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 15 metrics below, Tonix Pharmaceuticals Holding Corp. leads on 8 and Genelux Corporation on 7.

Valuation

Metric GNLX TNXP Biotechnology median
P/E n/m n/m 8.50
P/S 9.67 3.45 9.71
P/B 6.75 0.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.42 0.64
EV/Sales 8.77 (2.35) 9.21
Earnings yield (35.54%) (219.31%) (33.15%)
Free cash flow yield (26.36%) (157.36%) (25.50%)

Profitability

Metric GNLX TNXP Biotechnology median
Gross margin (3.42%) 83.83% 65.16%
Operating margin 0.00% (568.43%) 0.00%
Net margin 0.00% (548.64%) 0.00%
Free cash flow margin 0.00% (543.29%) 0.00%
Return on equity (177.93%) (81.82%) (56.36%)
Return on assets (121.80%) (72.34%) (48.04%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric GNLX TNXP Biotechnology median
Revenue growth (TTM) — 196.02% 6.02%
EPS growth (last fiscal year) 9.47% 91.75% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNLX TNXP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.39 6.61 4.72
Net debt to EBITDA 0.44 1.68 0.96

Dividend

Metric GNLX TNXP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNLX TNXP Biotechnology median
Market cap 112.21m 110.11m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack